Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).

Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S; TEENZ Study Group..

Headache. 2016 Jul;56(7):1107-19. doi: 10.1111/head.12859. Epub 2016 Jun 22.

PMID:
27329280
2.
3.

Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.

McIntyre RS, Gorwood P, Thase ME, Liss C, Desai D, Chen J, Bauer M.

J Clin Psychopharmacol. 2015 Dec;35(6):706-10. doi: 10.1097/JCP.0000000000000416.

4.

Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studies.

Brody RS, Liss CL, Wray H, Iovin R, Michaylira C, Muthutantri A, Damstetter P, Datto C, Jefferies L.

Int Clin Psychopharmacol. 2016 Jan;31(1):34-41. doi: 10.1097/YIC.0000000000000102.

PMID:
26451964
5.

Quantifying the Electron Donor and Acceptor Abilities of the Ketimide Ligands in M(N═C(t)Bu2)4 (M = V, Nb, Ta).

Damon PL, Liss CJ, Lewis RA, Morochnik S, Szpunar DE, Telser J, Hayton TW.

Inorg Chem. 2015 Oct 19;54(20):10081-95. doi: 10.1021/acs.inorgchem.5b02017. Epub 2015 Sep 30.

6.

Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials.

Vase L, Vollert J, Finnerup NB, Miao X, Atkinson G, Marshall S, Nemeth R, Lange B, Liss C, Price DD, Maier C, Jensen TS, Segerdahl M.

Pain. 2015 Sep;156(9):1795-802. doi: 10.1097/j.pain.0000000000000217.

PMID:
25955965
7.

Dopamine signaling in the medial prefrontal cortex and amygdala is required for the acquisition of fructose-conditioned flavor preferences in rats.

Malkusz DC, Banakos T, Mohamed A, Vongwattanakit T, Malkusz G, Saeed S, Martinez S, Bohn T, Mahmud F, Liss C, Rozvi A, Touzani K, Sclafani A, Bodnar RJ.

Behav Brain Res. 2012 Aug 1;233(2):500-7. doi: 10.1016/j.bbr.2012.05.004. Epub 2012 May 11.

8.

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.

Loftus JV, Sultan MB, Pleil AM; Macugen 1013 Study Group..

Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7498-505. doi: 10.1167/iovs.11-7613.

PMID:
21896838
9.

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults.

Musher DM, Manoff SB, McFetridge RD, Liss CL, Marchese RD, Raab J, Rueda AM, Walker ML, Hoover PA.

Hum Vaccin. 2011 Sep;7(9):919-28. doi: 10.4161/hv.7.9.15996. Epub 2011 Sep 1.

PMID:
21860256
10.

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.

Vesikari T, Martin JC, Liss CL, Liska V, Schödel FP, Bhuyan PK.

Pediatr Infect Dis J. 2011 Jul;30(7):e109-13. doi: 10.1097/INF.0b013e31821ed1a4.

PMID:
21552183
11.

A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.

Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS; Macugen 1013 Study Group..

Ophthalmology. 2011 Jun;118(6):1107-18. doi: 10.1016/j.ophtha.2011.02.045. Epub 2011 May 6.

PMID:
21529957
12.

Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.

Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, Painter C, Blum MD, Silber JL.

J Infect Dis. 2010 Feb 15;201(4):516-24. doi: 10.1086/649839.

PMID:
20092407
13.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
14.

Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.

Doherty R, Garland S, Wright M, Bulotsky M, Liss C, Lakkis H, Nikas A, Straus W.

Pediatr Infect Dis J. 2009 Sep;28(9):777-81. doi: 10.1097/INF.0b013e3181a06fad.

PMID:
19636283
15.

Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults.

Van Damme P, Minervini G, Liss CL, McCarson B, Vesikari T, Boslego JW, Bhuyan PK.

Hum Vaccin. 2009 Feb;5(2):92-7. Epub 2009 Feb 14.

PMID:
18690015
16.

Thoughts on farm animal welfare.

Liss C.

J Am Vet Med Assoc. 2007 Jan 15;230(2):185; author reply 186-7. No abstract available.

PMID:
17260419
18.

The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.

Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB.

Clin Pharmacol Ther. 2004 May;75(5):464-75.

PMID:
15116059
20.

Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasia.

Byrnes CA, Liss CL, Tenover JL, Lippert MC, Gillenwater JY.

Prostate Cancer Prostatic Dis. 1997 Sep;1(1):26-31.

Supplemental Content

Loading ...
Support Center